LGC Clinical Diagnostics Inc.

Milford, MA Doing business as LGC Clinical Diagnostics Clinical Diagnostics Part of Seracare Life Sciences Holdings, LLC

UEI
P94GFH7KA3F4
CAGE
3Y6A3
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
37 Birch St, Milford, MA 01757, USA
Website
lgcgroup.com
Founded
1996
Employees
1K-5K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

LGC Clinical Diagnostics Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
QI linearity reagents for MSU laboratory department. Contract · 75H70726P00141 Indian Health Service $14,400
(r) LGC clinical diagnostics, INC:1107053 [26-002116] Contract · 75N98026P00232 Office of Logisitics and Acquisition Operations $43,810
Laboratory linearity kits Contract · 36C25726P0113 Veterans Integrated Service Network 17 $73,974
Validation of the new roche instruments, cobas 5800 (r) LGC clinical diagnostics, INC:1107053 [25-009021] Contract · 75N90025P00676 NIH Clinical Center $18,840
25-004737- serological assays Contract · 75N90025P00229 NIH Clinical Center $13,460

About LGC Clinical Diagnostics Inc.

Written by GovTribe AI ·

LGC Clinical Diagnostics Inc., a foreign-owned manufacturer of clinical diagnostic products and reference materials, operates as a prime contractor supplying diagnostic equipment validation services, control products, calibration verification kits, laboratory panels, serological assays, and reagents to federal health agencies. The company competes exclusively in full-and-open procurements with no set-aside designations across its recent award footprint. LGC Clinical Diagnostics is a subsidiary of Seracare Life Sciences Holdings, LLC, headquartered in Milford, Massachusetts, and operates its Clinical Diagnostics Division under the doing-business-as name LGC Clinical Diagnostics.

The company's capability portfolio centers on clinical laboratory diagnostics and reference materials. Representative recent work includes a $43,810 firm fixed-price purchase order from the NIH Clinical Center (April 2026) for clinical diagnostic supplies, a $47,053.56 purchase order from the Defense Health Agency (September 2024) for calibration verification and linearity test kits for cardiac equipment and Maine standard reagents, a $77,990.25 purchase order from CDC Pittsburgh (September 2023) for laboratory panels, and a $18,840.40 purchase order from NIH Clinical Center (September 2025) for validation of Roche COBAS 5800 diagnostic equipment. The company also supplied serological assays ($13,459.86, March 2025), external run controls for antibody/antigen viral markers ($14,386.50, October 2024), and control products and reagents across multiple federal laboratory operations. LGC's experience includes COVID-19 response support through SARS-CoV-2 reference materials and other viral diagnostic products.

Customer concentration is heavily skewed toward Department of Health and Human Services agencies. The National Institutes of Health National Cancer Institute anchors the dollar footprint with two awards valued at $155.6 million combined potential value, while the NIH Clinical Center leads award volume with 13 awards ($215 thousand combined potential value). CDC agencies account for 22 awards ($2 million combined potential value), and the Department of Veterans Affairs Veterans Health Administration has placed 16 awards across two Veterans Integrated Service Networks ($427 thousand combined potential value). Top customers by award count represent 28% of all awards; top customers by potential value represent 99% of all dollars, reflecting extreme concentration in two large NIH awards against a broader base of smaller purchase orders.

LGC works under two named indefinite delivery contracts: VA24612D0014 (five task orders, $158 thousand combined potential value) and W81K0407D0023 (three task orders, $189 thousand combined potential value). Award activity has declined over the past three years — five awards in 2022, declining to two awards in both 2024 and 2025, with one award placed through April 2026. Only one award faces ultimate completion within the next twenty-four months (combined potential value $44 thousand), creating minimal recompete exposure. The company's classification spans in-vitro diagnostic substance manufacturing (58 awards), testing laboratories and services (10 awards), analytical laboratory instrument manufacturing (9 awards), and biological product manufacturing (6 awards), with PSC concentration in laboratory equipment and supplies (67 awards) and in-vitro diagnostic substances and reagents (37 awards). LGC operates with 181 total prime awards and zero sub awards, indicating an exclusive prime-contract posture with no significant subcontracting footprint.

Quick answers

What is LGC Clinical Diagnostics Inc.'s UEI?

LGC Clinical Diagnostics Inc.'s Unique Entity ID (UEI) in SAM.gov is P94GFH7KA3F4.

What is LGC Clinical Diagnostics Inc.'s CAGE code?

LGC Clinical Diagnostics Inc.'s CAGE code is 3Y6A3.

What is LGC Clinical Diagnostics Inc.'s primary NAICS code?

LGC Clinical Diagnostics Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is LGC Clinical Diagnostics Inc. located?

LGC Clinical Diagnostics Inc.'s physical address in SAM.gov is 37 Birch St, Milford, MA 01757, USA.

Is LGC Clinical Diagnostics Inc. registered in SAM.gov?

Yes. LGC Clinical Diagnostics Inc.'s SAM.gov registration is active through September 21, 2027.

Who is LGC Clinical Diagnostics Inc.'s parent company?

LGC Clinical Diagnostics Inc. is part of Seracare Life Sciences Holdings, LLC.

What is LGC Clinical Diagnostics Inc.'s most recent federal award?

LGC Clinical Diagnostics Inc.'s most recent federal contract award is QI linearity reagents for MSU laboratory department (75H70726P00141), from Indian Health Service, on October 1, 2026.

On GovTribe

See LGC Clinical Diagnostics Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login